Knoll G - Search Results

1

Enteric-coated mycophenolate sodium can be safely administered in maintenance renal transplant patients: results of a 1-year study.

Budde K, Curtis J, Knoll G, Chan L, Neumayer HH, Seifu Y, Hall M; ERL B302 Study Group. Budde K, et al. Among authors: knoll g. Am J Transplant. 2004 Feb;4(2):237-43. doi: 10.1046/j.1600-6143.2003.00321.x. Am J Transplant. 2004. PMID: 14974945 Free article. Clinical Trial.

2

The impact of renal transplantation on survival in hepatitis C-positive end-stage renal disease patients.

Knoll GA, Tankersley MR, Lee JY, Julian BA, Curtis JJ. Knoll GA, et al. Am J Kidney Dis. 1997 Apr;29(4):608-14. doi: 10.1016/s0272-6386(97)90345-0. Am J Kidney Dis. 1997. PMID: 9100052

3

The care of patients undergoing hemodialysis.

Knoll G, Curtis J. Knoll G, et al. N Engl J Med. 1999 Mar 4;340(9):736-7. N Engl J Med. 1999. PMID: 10068335 No abstract available.

4

The burden of chronic kidney disease in renal transplant recipients.

Karthikeyan V, Karpinski J, Nair RC, Knoll G. Karthikeyan V, et al. Among authors: knoll g. Am J Transplant. 2004 Feb;4(2):262-9. doi: 10.1046/j.1600-6143.2003.00315.x. Am J Transplant. 2004. PMID: 14974949 Free article.

5

Safety and efficacy after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium: results of a 1-year extension study.

Budde K, Knoll G, Curtis J, Kahana L, Pohanka E, Seifu Y, Neumayer HH. Budde K, et al. Among authors: knoll g. Transplant Proc. 2005 Mar;37(2):912-5. doi: 10.1016/j.transproceed.2004.12.048. Transplant Proc. 2005. PMID: 15848573 Clinical Trial.

6

Patient survival following renal transplant failure in Canada.

Knoll G, Muirhead N, Trpeski L, Zhu N, Badovinac K. Knoll G, et al. Am J Transplant. 2005 Jul;5(7):1719-24. doi: 10.1111/j.1600-6143.2005.00921.x. Am J Transplant. 2005. PMID: 15943631 Free article.

7

Long-term safety and efficacy after conversion of maintenance renal transplant recipients from mycophenolate mofetil (MMF) to enteric-coated mycophenolate sodium (EC-MPA, myfortic).

Budde K, Knoll G, Curtis J, Chan L, Pohanka E, Gentil M, Seifu Y, Marrast AC, Neumayer HH; ERL B302 Study Group. Budde K, et al. Among authors: knoll g. Clin Nephrol. 2006 Aug;66(2):103-11. Clin Nephrol. 2006. PMID: 16939066 Clinical Trial.

8

Lack of benefit of early protocol biopsies in renal transplant patients receiving TAC and MMF: a randomized study.

Rush D, Arlen D, Boucher A, Busque S, Cockfield SM, Girardin C, Knoll G, Lachance JG, Landsberg D, Shapiro J, Shoker A, Yilmaz S. Rush D, et al. Among authors: knoll g. Am J Transplant. 2007 Nov;7(11):2538-45. doi: 10.1111/j.1600-6143.2007.01979.x. Epub 2007 Oct 1. Am J Transplant. 2007. PMID: 17908280 Free article. Clinical Trial.

9

Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis.

Mulay AV, van Walraven C, Knoll GA. Mulay AV, et al. Among authors: knoll ga. Am J Transplant. 2009 Apr;9(4):804-11. doi: 10.1111/j.1600-6143.2009.02554.x. Am J Transplant. 2009. PMID: 19353768 Free article.

10

Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil.

Rush DN, Cockfield SM, Nickerson PW, Arlen DJ, Boucher A, Busque S, Girardin CE, Knoll GA, Lachance JG, Landsberg DN, Shapiro RJ, Shoker A, Yilmaz S. Rush DN, et al. Transplantation. 2009 Oct 15;88(7):897-903. doi: 10.1097/TP.0b013e3181b723f4. Transplantation. 2009. PMID: 19935461 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

422 results

Search Page

Filters